The effects of the selective muscarinic M3 receptor antagonist darifenacin, and of hyoscine (scopolamine), on motion sickness, skin conductance & cognitive function

Por Golding, John F., Wesnes, Keith A., Leaker, Brian R.
Publicado no Br J Clin Pharmacol (2018)

Embodied perspective-taking indicated by selective disruption from aberrant self motion

Por Gardner, Mark R., Stent, Chloé, Mohr, Christine, Golding, John F.
Publicado no Psychol Res (2016)

Reliability of functional outcome measures in adults with neurofibromatosis 1

Por Mullin, Rebecca L, Golding, John F, Smith, Rebecca, Williams, Victoria, Thomas, Mary, Ferner, Rosalie E
Publicado no SAGE Open Med (2018)

Motion sickness in migraine and vestibular disorders

Por Murdin, Louisa, Chamberlain, Florence, Cheema, Sanjay, Arshad, Qadeer, Gresty, Michael A, Golding, John F, Bronstein, Adolfo
Publicado no J Neurol Neurosurg Psychiatry (2015)

Vestibular Perception following Acute Unilateral Vestibular Lesions

Por Cousins, Sian, Kaski, Diego, Cutfield, Nicholas, Seemungal, Barry, Golding, John F., Gresty, Michael, Glasauer, Stefan, Bronstein, Adolfo M.
Publicado em 2013

Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire

Por Ferner, Rosalie E, Thomas, Mary, Mercer, Gemma, Williams, Victoria, Leschziner, Guy D, Afridi, Shazia K, Golding, John F
Publicado no Health Qual Life Outcomes (2017)

Visual Dependency and Dizziness after Vestibular Neuritis

Por Cousins, Sian, Cutfield, Nicholas J., Kaski, Diego, Palla, Antonella, Seemungal, Barry M., Golding, John F., Staab, Jeffrey P., Bronstein, Adolfo M.
Publicado em 2014

The NFTI-QOL: A Disease-Specific Quality of Life Questionnaire for Neurofibromatosis 2

Por Hornigold, Rachael E., Golding, John F., Leschziner, Guy, Obholzer, Rupert, Gleeson, Michael J., Thomas, Nick, Walsh, Daniel, Saeed, Shakeel, Ferner, Rosalie E.
Publicado em 2012

Electrocortical therapy for motion sickness

Por Arshad, Qadeer, Cerchiai, Niccolo, Goga, Usman, Nigmatullina, Yuliya, Roberts, R. Ed, Casani, Augusto P., Golding, John F., Gresty, Michael A., Bronstein, Adolfo M.
Publicado no Neurology (2015)

Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2

Por Ferner, Rosalie E., Shaw, Adam, Evans, D. Gareth, McAleer, Dympna, Halliday, Dorothy, Parry, Allyson, Raymond, F. Lucy, Durie-Gair, Juliette, Hanemann, C. Oliver, Hornigold, Rachel, Axon, Patrick, Golding, John F.
Publicado em 2014

Bevacizumab in neurofibromatosis type 2 (NF2) related vestibular schwannomas: a nationally coordinated approach to delivery and prospective evaluation

Por Morris, Katrina A., Golding, John F., Axon, Patrick R., Afridi, Shazia, Blesing, Claire, Ferner, Rosalie E., Halliday, Dorothy, Jena, Raj, Pretorius, Pieter M., Evans, D. Gareth, McCabe, Martin G., Parry, Allyson
Publicado no Neurooncol Pract (2016)